文献速递肝病

纤囊蛋白缺失通过白细胞介素-8依赖途径促进胆管上皮增殖及结缔组织生长因子产生

Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium.
PubMed 文献 · J Hepatol · 2019-03-19

本研究利用CRISPR/Cas9构建PKHD1敲除与杂合突变的人诱导多能干细胞模型,在三维培养中分化为胆管样囊泡。结果显示PKHD1敲除囊泡中IL-8自分泌显著增加,经MAPK通路促进增殖,并以IL-8依赖方式增加CTGF产生;先天性肝纤维化患者血清IL-8及肝组织IL-8、CTGF表达亦显著升高。

要点

  • PKHD1敲除胆管样囊泡中IL-8自分泌显著增加,进而促进增殖。
  • PKHD1敲除囊泡以IL-8依赖方式增加CTGF产生。
  • 先天性肝纤维化患者血清IL-8及肝组织IL-8、CTGF表达显著升高。

核心结论

  • 纤囊蛋白功能缺失通过IL-8依赖途径促进人胆管细胞增殖及CTGF产生。
  • IL-8和CTGF可能是先天性肝纤维化发病的关键分子及候选治疗靶点。

研究设计与样本

  • 研究利用RNA引导的CRISPR/Cas9基因组编辑建立PKHD1敲除及杂合突变的人诱导多能干细胞克隆。
  • 将iPS克隆在三维培养系统中分化为囊泡内的胆管样细胞(胆管样囊泡)。
  • 胆管样囊泡由单层胆管样细胞组成。
  • 进一步在先天性肝纤维化患者样本中进行验证分析。

主要发现

  • PKHD1敲除胆管样囊泡的增殖被自分泌的IL-8显著增加。
  • PKHD1敲除胆管样囊泡中IL-8产生显著升高,由纤囊蛋白缺陷引起的丝裂原活化蛋白激酶通路激活所致。
  • PKHD1敲除胆管样囊泡中CTGF产生以IL-8依赖方式增加。
  • 验证分析显示先天性肝纤维化患者血清IL-8水平及肝样本中IL-8和CTGF表达均显著升高,与体外人类iPS疾病模型一致。

临床怎么用

  • 作者认为IL-8和CTGF是先天性肝纤维化发病的关键分子,并是候选治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Congenital hepatic fibrosis (CHF) is a genetic liver disease resulting in abnormal proliferation of cholangiocytes and progressive hepatic fibrosis. CHF is caused by mutations in the PKHD1 gene and the subsequent dysfunction of the protein it encodes, fibrocystin. However, the underlying molecular mechanism of CHF, which is quite different from liver cirrhosis, remains unclear. This study investigated the molecular mechanism of CHF pathophysiology using a genetically engineered human induced pluripotent stem (iPS) cell model to aid the discovery of novel therapeutic agents for CHF. METHODS: PKHD1-knockout (PKHD1-KO) and heterozygously mutated PKHD1 iPS clones were established by RNA-guided genome editing using the CRISPR/Cas9 system. The iPS clones were differentiated into cholangiocyte-like cells in cysts (cholangiocytic cysts [CCs]) in a 3D-culture system. RESULTS: The CCs were composed of a monolayer of cholangiocyte-like cells. The proliferation of PKHD1-KO CCs was significantly increased by interleukin-8 (IL-8) secreted in an autocrine manner. IL-8 production was significantly elevated in PKHD1-KO CCs due to mitogen-activated protein kinase pathway activation caused by fibrocystin deficiency. The production of connective tissue growth factor (CTGF) was also increased in PKHD1-KO CCs in an IL-8-dependent manner. Furthermore, validation analysis demonstrated that both the serum IL-8 level and the expression of IL-8 and CTGF in the liver samples were significantly increased in patients with CHF, consistent with our in vitro human iPS-disease model of CHF. CONCLUSIONS: Loss of fibrocystin function promotes IL-8-dependent proliferation of, and CTGF production by, human cholangiocytes, suggesting that IL-8 and CTGF are essential for the pathogenesis of CHF. IL-8 and CTGF are candidate molecular targets for the treatment of CHF. LAY SUMMARY: Congenital hepatic fibrosis (CHF) is a genetic liver disease caused by mutations of the PKHD1 gene. Dysfunction of the protein it encodes, fibrocystin, is closely associated with CHF pathogenesis. Using an in vitro human induced pluripotent stem cell model and patient samples, we showed that the loss of fibrocystin function promotes proliferation of cholangiocytes and the production of connective tissue growth factor (CTGF) in an interleukin 8 (IL-8)-dependent manner. These results suggest that IL-8 and CTGF are essential for the pathogenesis of CHF.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Tsunoda T, Kakinuma S, Miyoshi M, et al. Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium. J Hepatol. 2019. PMID: 30898581. doi:10.1016/j.jhep.2019.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。